Sonoma pharmaceuticals launches two new products expanding its line of office dispense products exclusively for dermatologists and medical spas

Boulder, co / accesswire / january 4, 2023 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including dermatology, eye, oral and nasal care, and wound care today announced that it has launched a line of office dispense products exclusively for skin care professionals. the products include regenacyn® plus, reliefacyn® plus, and rejuvacyn® plus, all in prescription strength formulations.
SNOA Ratings Summary
SNOA Quant Ranking